Literature DB >> 27084373

[Postoperative radiation therapy for endometrial cancer : Rigorous and evidence-based processing of data still required].

Simone Marnitz1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27084373     DOI： 10.1007/s00066-016-0954-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  21 in total

1.  Endometrial cancer and lymph node surgery: the spins continue--a case for reason.

Authors:  Richard C Boronow
Journal:  Gynecol Oncol       Date:  2008-08-09       Impact factor: 5.482

Review 2.  Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

Authors:  B E Hillner; T J Smith; C E Desch
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

3.  Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Authors:  A Gaudineau; D Weitbruch; P Quetin; S Heymann; T Petit; P Volkmar; F Bodin; M Velten; J F Rodier
Journal:  Oncol Lett       Date:  2012-07-27       Impact factor: 2.967

4.  L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: pooled PORTEC trial results.

Authors:  T Bosse; R A Nout; E Stelloo; E Dreef; H W Nijman; I M Jürgenliemk-Schulz; J J Jobsen; C L Creutzberg; V T H B M Smit
Journal:  Eur J Cancer       Date:  2014-08-07       Impact factor: 9.162

5.  Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.

Authors:  R A Nout; V T H B M Smit; H Putter; I M Jürgenliemk-Schulz; J J Jobsen; L C H W Lutgens; E M van der Steen-Banasik; J W M Mens; A Slot; M C Stenfert Kroese; B N F M van Bunningen; A C Ansink; W L J van Putten; C L Creutzberg
Journal:  Lancet       Date:  2010-03-06       Impact factor: 79.321

6.  Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study.

Authors:  Deborah Watkins Bruner; Andrea Barsevick; Chunqiao Tian; Marcus Randall; Robert Mannel; David E Cohn; Joel Sorosky; Nick M Spirtos
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 4.147

7.  Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: a SEER registry analysis.

Authors:  Peter J Rossi; Ashesh B Jani; Ira R Horowitz; Peter A S Johnstone
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-12       Impact factor: 7.038

Review 8.  Adjuvant chemotherapy in endometrial carcinoma: overview of randomised trials.

Authors:  T Hogberg
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-05-07       Impact factor: 4.126

9.  The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.

Authors:  Angeles Alvarez Secord; Laura J Havrilesky; Victoria Bae-Jump; Jeanette Chin; Brian Calingaert; Amy Bland; Teresa L Rutledge; Andrew Berchuck; Daniel L Clarke-Pearson; Paola A Gehrig
Journal:  Gynecol Oncol       Date:  2007-08-06       Impact factor: 5.482

10.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study.

Authors:  H Kitchener; A M C Swart; Q Qian; C Amos; M K B Parmar
Journal:  Lancet       Date:  2008-12-16       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.